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Free radicalsVarious nutritional, behavioral, and pharmacological interventions have been previously shown to extend
life span in diverse model organisms, including Saccharomyces cerevisiae, Caenorhabditis elegans, Drosophila
melanogaster, mice, and rats, as well as possibly monkeys and humans. This review aims to summarize
published evidence that several longevity-promoting interventions may converge by causing an activation of
mitochondrial oxygen consumption to promote increased formation of reactive oxygen species (ROS). These
serve as molecular signals to exert downstream effects to ultimately induce endogenous defense mechanisms
culminating in increased stress resistance and longevity, an adaptive response more speciﬁcally named
mitochondrial hormesis or mitohormesis. Consistently, we here summarize ﬁndings that antioxidant
supplements that prevent these ROS signals interfere with the health-promoting and life-span-extending
capabilities of calorie restriction and physical exercise. Taken together and consistent with ample published
evidence, the ﬁndings summarized here question Harman's Free Radical Theory of Aging and rather suggest
that ROS act as essential signaling molecules to promote metabolic health and longevity.utrition, Institute of Nutrition,
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Calorie restriction (CR), i.e., a reduction in ad libitum calorie up-
take by 10 to 50%, represents the most convincing intervention to
retard aging and attenuate age-related disease in multiple species.
Since 1935, when McCay initially described the inﬂuence of CR on life
expectancy, it has been frequently demonstrated that CR is able to
increase the median and maximal life span in a variety of organisms,
suggesting a conserved underlying mechanism [1,2].Although CR clearly reduces risk factors associated with aging in
humans, including type 2 diabetes and cardiovascular diseases, it is still
a matter of debate whether CR is capable of increasing life expectancy
of humans [3–5]. A recent study in nonhuman primates found no
signiﬁcant effect of CR on overall mortality. However, arbitrarily
deﬁned “age-related mortality” (which moreover explained only 54%
of deaths) was decreased in those monkeys. Most interestingly and
contrasting with ad libitum-fed animals, monkeys on CR did not show
any impairment in glucose homeostasis, strikingly reducing the
prevalence of metabolic disorders such as type 2 diabetes [6]. Thus, it
seems possible that CR is also sufﬁcient to improve the life span of
humans, which is also supported by additional ﬁndings [3–5,7,8].
The concept of CR was initially based on the assumption that
lowering caloric intake would result in a subsequent reduction of the
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century that the maximum life span of an organism is inversely
proportional to the nutritive energy metabolized [9]. Consequently,
Pearl's Rate-of-Living Hypothesis, formulated soon after, suggests that
increased metabolic rate results in decreased life span in eukaryotes
[10].
A feasible molecular cause for this hypothesis was proposed in
1956 by Harman, who connected metabolic activity, especially that
of respiratory enzymes, with the formation of potentially harmful
reactive oxygen species (ROS) [11]. Accordingly, increased metabolic
rate would promote ROS formation, which subsequently causes
damages within the cell and beyond. The accumulation of these
damages results in age-related decline of cellular functions and
ultimately to death of the organism [11]. Up to now, this so-called Free
Radical Theory of Aging (FRTA) has become a popular and frequently
cited theory in aging research [12].
However, more recent ﬁndings regarding the question whether
CR actually decreases metabolic rate are, at least in part, inconsistent
with FRTA. Hence, it has been reported that CR increases metabolic
rate (quantiﬁed by both oxygen consumption and heat production) in
the nematode and well-established model organism for aging
research, Caenorhabditis elegans [13]. Furthermore, a positive corre-
lation between low metabolic rate and enhanced life span could also
not be observed in the fruitﬂy Drosophila melanogaster [14].
Despite the fact that CR has been extensively investigated in a
broad range of species, the underlyingmechanisms are still elusive. As
mentioned above, it is commonly accepted that CR is able to retard the
onset of a variety of diseases related to aging, including cardiovascular
diseases, type 2 diabetes, and cancer. Therefore, CR-mediated pre-
vention of chronic and ultimately life-threatening disorders that
reduce longevity could be the reason for the life-span-extending
effects of CR. Additionally, it has been shown that CR itself stimulates
molecular processes that diminish age-associated disease as well as
improving life expectancy. Accordingly, it was frequently reported
that CR induces defense mechanisms, especially those that are
involved in ROS detoxiﬁcation such as radical-scavenging enzymes
[15–22] and possibly beyond, including phase II response enzymes.
This association of CR on the one hand and increased antioxidant
defense on the other has been commonly misinterpreted as being
caused by a primarily decreased ROS production in states of CR.
Conversely, and as explained in more detail below, more recent
investigations suggest that adaptive response mechanisms seem to be
the cause of the aforementioned beneﬁcial alterations unquestionably
initiated by CR [23–27].
Reduction of speciﬁc macronutrients
Macronutrients are represented by carbohydrates, triglycerides,
and proteins, which, after experiencing enzymatic breakdown, are
ultimately metabolized as monosaccharides (such as glucose), fatty
acids, and amino acids, respectively. They provide the bulk of energy
required by the organism. In this regard it should be noted, however,
that only glucose can be metabolized in the absence of oxygen. In
contrast, ATP generation using fatty acids and some amino acids
requires mitochondrial oxidative phosphorylation (OxPhos) and
therefore oxygen. Inversely, only metabolism of glucose can generate
ATP independent of mitochondrial organelles and hence without
promoting ROS production.
So far, only a few studies have investigated the question whether
restricting a single macronutrient can cause a response comparable to
that seen in states of general CR. Whereas restriction of triglyceride
uptake in invertebrates has not been examined yet, restriction of
lipids in mice without CR does not inﬂuence life span [28].
The inﬂuence of dietary protein levels on life span has been
investigated primarily in D. melanogaster and rodents. Accordingly, it
was shown that reduction of nutritive protein content results inextension of life expectancy in mice [29–31]. Similarly, casein
restriction prolongs life span in D. melanogaster [32]. On the other
hand, supplementation of essential amino acids, especially methio-
nine, abolishes the life-span-extending effect of CR in ﬂies [33].
Interestingly, methionine restriction in rodents has been shown to
exert antiaging properties and improves tissue-speciﬁc mitochondrial
biogenesis as well as aerobic capacity [34–36], whereas high protein
intake results in increased lipid peroxidation and reduced superoxide
dismutase activity [37]. Consistently, impaired peptide transport
extents life span in C. elegans [38].
In apparent contrast to the above-mentioned fact that ATP
generation from glucose is capable of avoiding ROS production,
glucose restriction has been found to be beneﬁcial in various lower
organisms as well as in rodents. In D. melanogaster, for instance,
restriction of sugar reduces mortality and extends life span [39]. The
same applies for the model organism Saccharomyces cerevisiae, in
which depletion of glucose results in life-span extension dependent
on induction of respiration as well as on sirtuins [40,41]. However,
whether sirtuins are involved is still a matter of debate [42–45].
Accordingly, sirtuin-independent pathways have been discussed
[22,46].
Although it is generally difﬁcult to restrict dietary glucose in
eukaryotic organisms such as C. elegans or rodents, the use of 2-
deoxyglucose (DOG) is frequently reported to achieve depletion of
glucose metabolism [47]. DOG is a synthetic glucose analogue that
inhibits glycolysis in a competitive manner due to its inability to be
further metabolized after conversion into deoxyglucose 6-phosphate
[48]. Application of DOG was shown to mimic a ketogenic diet (very
low carbohydrate diet) as well as metabolic hallmarks of CR in rodents
[49–51]. It is therefore commonly accepted that DOG represent a
powerful CR-mimetic compound [52–55].
DOG exposure results in decreased glucose availability and life-
span extension in C. elegans [23], whereas it does not extend life span
in rats [56]. Notably, and similar to the above-mentioned ﬁndings in S.
cerevisiae, glucose restriction in C. elegans not only promotes life span
but also increases oxygen consumption [23]. However, and in contrast
to yeast, in nematodes sirtuins seem not to be involved [23]. It was
suggested instead that the underlying mechanism in regard to life-
span prolongation is dependent on AMP-activated kinase (AMPK)
[23]. AMPK is assumed to be a central key regulator of energy
metabolism within the cell [57]. Functionally similar AMPK ortholo-
gues have been found in lower organisms such as worms and ﬂies,
suggesting a highly conserved mechanism [58–60]. Metabolic stress,
e.g., cellular lack of energy, activates AMPK, which in turn up-
regulates energy-producing processes such as mitochondrial biogen-
esis leading to neutralization of the energy deﬁcit, possibly with
additional health-promoting implications [57]. Consistently, applying
metformin, a long-standing antidiabetic drug, to C. elegans activates
AMPK and subsequently promotes adaptive processes involved in CR
and oxidative stress response, culminating in extended life span [61].
As an alternative approach to inﬂuencing intracellular glucose
concentrations in mammals, mice with impaired GLUT-4 transporters
in muscle and adipose tissue were established. These mice show
typical metabolic switches such as fasting hyperglycemia, glucose
intolerance, increased fatty acid turnover, and utilization. However,
life span (examined up to 18 months of age) was not affected [62].
Increased cellular glucose availability due to overexpression of GLUT-
4, on the other hand, was also shown to lack any effect regarding
extension of life span [63]. In addition, increased glucose abundance
in C. elegans, examined in three independent studies, reduces life span
signiﬁcantly [23,64,65].
In humans, varying the relative amounts of macronutrients within
diets has been postulated to be health beneﬁcial in regard to obesity
and cardiovascular disease prevention. Although low-carbohydrate/
high-protein diets are as efﬁcient as low-fat/high-carbohydrate diets
in regard to weight loss, serum parameters known to determine
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reduction in dietary carbohydrate consumption [66–68]. Very low
carbohydrate diet has been also demonstrated to reduce several
inﬂammation markers in overweight men and women with athero-
genic dyslipidemia [69]. However, more research, especially long-
term studies, is needed to evaluate the putative effect of low-carbo-
hydrate diets on human health.
Impaired insulin/IGF-1 signaling
In mammals, insulin and IGF-1 represent peptide hormones
produced in pancreatic β-cells and liver, respectively. Insulin is a
regulator of the peripheral glucose metabolism, most notably glucose
uptake. In addition, insulin is also involved in other metabolic
processes such as fat metabolism. IGF-1 is produced as a consequence
of growth hormone (GH) (also called somatotropin) release from the
pituitary gland, which stimulates subsequently IGF-1 production in
the liver. IGF-1 is therefore a mediator for some of the GH functions,
thus involved in growth and anabolism. Insulin, IGF-1, and GH
mediate their effects by binding at speciﬁc and distinct receptors in
mammals.
Mice with reduced GH and/or IGF-1 signaling exhibit dwarﬁsm
with a phenotype that is comparable to those of mice exposed to CR
[70]. As shown for CR, those mice are also long-lived [71]. Conversely,
increasing GH availability leads to improved body size and diminishes
life expectancy [72,73]. Furthermore, heterozygote impairment of the
IGF-1 receptor signaling in the entire animal, as well as impairment of
the IGF-1 receptor in neurons, results in life-span extension inmice by
preventing neurodegenerative processes [74,75]. Conversely, long-
term IGF-1 exposure leads to mitochondrial dysfunction and reduced
cell viability in human cell culture [76].
Down-regulation of insulin receptor activity in humans is assumed
to be a cause for insulin resistance. This state is deﬁned as an inappro-
priate reduction in the intracellular response to extracellular insulin
[77]. Consequently, a reduction in GLUT-4-mediated glucose uptake,
which represents a key insulin response, occurs. Therefore, intracel-
lular glucose availability is reduced in subjects suffering from insulin
resistance [78].
However, despite the fact that global disturbance of the insulin
receptor in mice results in a prenatally lethal phenotype, muscle-
speciﬁc knockout mice experience neither hyperglycemia nor
diabetes. Instead, a remarkable rise in fatty acid turnover has been
observed [79]. Although life-span data on these mice are unavailable,
disruption of the insulin receptor in adipose tissue only causes
prolongation of life span [80]. Moreover, disruption of the insulin
receptor substrate 1 (IRS-1), which is localized downstream of both
the insulin and the IGF-1 receptors, is associated with murine lon-
gevity as well as knockouts of neuronal IRS-2 and heterozygous global
IRS-2 [81,82].
Moreover, and as initially published more than 20 years ago,
impaired insulin/IGF-1 signaling strikingly prevents aging in inverte-
brates. Whereas in mammals insulin and IGF-1 bind to speciﬁc and
distinct receptors, in C. elegans and D. melanogaster insulin and IGF-1
signaling is limited to one receptor. Hence, mutations in the corre-
sponding receptor orthologues as well as in downstream components
were shown to be life-span extending in worms and ﬂies in a manner
even more pronounced than in mammals [83–87]. C. elegans daf-2
mutants, which show impaired activity of the orthologue of the
mammalian insulin/IGF-1 receptor, live twice as long as wild-type
nematodes [84]. Although it is not known whether glucose uptake or
intracellular glucose availability is affected in this regard, a very recent
work on daf-2 mutants indicates that the age-associated decline in
mitochondrial activity, e.g., mitochondrial protein content and energy
supply, is delayed in comparison to wild-type animals [88].
In summary, it seems that reduction of the insulin receptor as well
as insulin receptor substrate below a certain threshold contributes tolongevity in a variety of organisms, including worms, ﬂies, and mice.
This may be also relevant to humans because mutations of insulin/
IGF-1 signaling have been linked to regulation of life expectancy in
various cohorts [89,90].
Whether reduced insulin/IGF-1/GH signaling lengthens life span in
the same manner as CR is an ongoing matter of debate. Although
several studies have demonstrated independent mechanisms, others
have proposed that similar pathways and processes are initiated
by both interventions [59,91–101]. Based on the assumption that
mutations associated with impaired insulin/IGF-1 signaling cause
reduced intracellular glucose availability, it seems likely that
subsequent effects are comparable to those seen in glucose-restricted
model organisms, at least in regard to metabolic shifts and also
possibly life-span-extending mechanisms. Although to date direct
evidence is missing, some studies provide support for this hypothesis
[102–106].
Induction of mitochondrial metabolism by calorie/glucose
restriction
In general, mitochondria are cellular organelles that provide the
bulk of energy within the cell. ATP generation due to mitochondrial
OxPhos is considerably more efﬁcient in comparison to nonoxidative
metabolism of glucose and some amino acids. Whereas glycolytic
breakdown of 1 mol of glucose generates 4 mol of ATP, its oxidative
metabolism produces 30 mol of ATP. Mitochondria also produce ROS
as a by-product of OxPhos. Thus, being the main producer of cellular
energy as well as a source of potentially harmful ROS, mitochondria
appear to exert a central role in physiological and pathophysiological
processes.
Accordingly, mitochondrial dysfunction is associated with the
onset of age-related diseases such as diabetes, cancer, and neurode-
generation [107–110]. Furthermore, impairment of mitochondrial
activity is assumed to be a main cause of the aging process [111,112].
Whether this decrease in mitochondrial capacity is linked to altered
production of mitochondrial ROS seems questionable.
Although a few studies suggested that overall net calorie uptake
during the lifetime is unaltered in CR [39,113], it is commonly
accepted and agreed upon that by deﬁnition calorie/glucose restric-
tion causes a reduction in available nutritive energy. This short-term
energy deﬁcit has been proposed to induce mitochondrial activity to
counteract the energy depletion. Accordingly, calorie/glucose restric-
tion causes an increase in mitochondrial respiration in yeast and
worms [23–25,40]. Enhanced mitochondrial activity is, as shown in
these studies, associated with life-span extension [23–25,40]. Fur-
thermore, CR promotes mitochondria biogenesis and OxPhos in
rodents as well as enhancement of respiratory capacity in mammalian
cells [114,115]. These results are in line with the observation that
energy expenditure as a function of body mass is unexpectedly
increased in calorie-restricted rats [116]. Moreover, as mentioned
before, reduced insulin/IGF-1/GH signaling stimulates mitochondria
metabolism in rodents [102,104–106]. In addition, an abundant
supply of branched-chain amino acids increases mitochondrial
biogenesis and promotes longevity in yeast and mice [117,118].
Finally, further interventions that induce mitochondrial activity, such
as pharmacological treatments and physical exercise, are capable of
improving life span [119–123].
In contrast, and as mentioned before, reduced mitochondrial
activity has been shown to decrease life span in various organisms
such as S. cerevisiae, C. elegans, and rodents [124–126].
In regard to proposed mechanisms involved in the activation of
mitochondrial metabolism some key cellular regulators have been
frequently reported, including the previously mentioned sirtuins
and AMPK. Activation of these proteins is associated with increased
mitochondria activity. In contrast, impairment of another nutrient-
sensing pathway, mTOR (mammalian target of rapamycin), was
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metabolism [127,128]. Consistently, the translational inhibitor 4E-BP,
which is repressed by TOR, regulates mitochondrial activity in CR ﬂies
[129]. Furthermore, TOR signaling has been shown to be regulated by
AMPK, suggesting that both nutrient-sensing pathways are located
upstream of mitochondria function, thereby representing key regu-
lators of mitochondrial metabolism [130].
Taken together, there are numerous studies linking mitochondrial
activity with prolongation of life expectancy, suggesting that a meta-
bolic switch to oxidative metabolism seems to be beneﬁcial in regard
to delay aging and the onset of age-related diseases.
Oxidative stress and mitochondrial hormesis (mitohormesis)
Increased ROS formation as a consequence of increased metabolic
rate has been postulated to be the major determinant of life span [11].
Becausemitochondria are an intracellular source of ROS, the theorywas
extended to the mitochondrial free radical theory [131], without the
knowledge that meanwhile the fact that increased metabolic rate does
not necessarily result in increased ROS formation had been established.
Thus, signiﬁcant research has been done to prove this hypothesis with
inconsistent and partly contradictive results [132]. However, a
considerable number of ﬁndings in various organisms suggest that
reduction of oxidative stress is associated with prolongation of life
expectancy [133–147]. Consequently, ROS-lowering interventions
were widely proposed as an antiaging strategy in humans. Antioxi-
dants, a group of synthetic or naturally occurring substances, which are
capable of scavenging free radicals, were extensively examined in that
regard. Unexpectedly and in contrast to some of the above-mentioned
work in lower organisms, several prospective clinical intervention
studies were unable to show a positive association between supple-
mentation with antioxidants and health-beneﬁcial effects. Whereas
most studies found a lack of effect in regards to health promotion in
humans [148–162], other reports even suggest that antioxidants may
promote cancer growth [163–168]. Moreover, supplementation with
antioxidants has been linked to increased incidence of a number of
diseases with adverse effects on human longevity [169–175].
Not surprisingly, these ﬁndings question Harman's FRTA and
require a different point of view concerning the role of mitochondrial
ROS formation. Accordingly, numerous ﬁndings have emerged in
recent years indicating that ROS may evoke cellular signaling that
promotes metabolic health and longevity. It has been assumed that
they serve as essential signaling molecules delivering messages
from the mitochondria to other cellular compartments in response
to physiological or pathophysiological changes [23,176–190]. More-
over, and given the increased levels of oxidative damage during
increasing age, intrinsic aging may be considered an insufﬁcient
ability to respond to endogenous ROS signals.
Interestingly, exposure of C. elegans to hyperbaric conditions
results in stress resistance and prolongation of life expectancy,
whereas such conditions cause an increase in mitochondrial ROS
formation [191–194]. Hypothermia, a state that is associated with
extend life span in mice and C. elegans [195,196], has been recently
shown to induce mitochondrial ROS production as well [197]. More-
over, it was shown that CR also induces low-level stress leading to
the same adaptive processes, such as increased stress resistance and
longevity [21,26,198–200].
These ﬁndings insinuate that so-called adaptive response process-
es may explain how increased ROS formation culminates in
promotion of health and life span. Interestingly, low doses of ROS
seem to exert such effects, whereas higher doses are unquestionably
detrimental. Such biphasic responses to a potentially harmful com-
pound are commonly named hormesis, a concept that was initially
postulated in 1943 by Southam and Ehrlich and which was shown to
have signiﬁcant impact on aging with a variety of stressors described
[201–205]. Later, this term was extended to mitochondrial hormesisor mitohormesis, with regard to mitochondrial ROS as a hypotheti-
cally sublethal stressor [206].
In agreement with this concept, it has been frequently reported
that rodents exposed to CR exhibit elevated antioxidant defense
capacities [15–20,207]. Furthermore, life-extending glucose restric-
tion in yeast was shown to be accompanied by a decrease in ROS
production, whereas respiration was enhanced [22]. On the other
hand and in conﬂict with these data, it was also reported that
the same intervention in the same model organism increases
ROS production as well as respiration [23–25,43,208,209]. Moreover,
antioxidant enzyme activity was found to be elevated as well
[24,43,208,209], suggesting a potential involvement of increased
respiration, enhanced ROS formation, and the induction of ROS
defense mechanisms in regard to regulation of longevity.
Consistently, numerous studies using various model organisms
were unable to ﬁnd any evidence to support that lowering ROS is
beneﬁcial in regard to longevity, nor that increasing antioxidant
capacity extends life span [210–227]. Moreover, life-span-extending
mutations in C. elegans are commonly accompanied by increased
stress resistance and sometimes paralleled by enhanced metabolic
activity [228–233]. Furthermore, in the ﬁeld of neuroprotective
research, similar hormetic results were achieved with CR as well as
DOG application in rodents [234]. Depletion of mitochondrial NADH
kinase, an enzyme crucial for antioxidant defense, causes life-span
extension and DNA stability due to adaptivemechanisms in Podospora
anserine [235]. Finally, human subjects on a carbohydrate-depleted
diet (i.e., a ketogenic diet) show improved ROS defense capacity
presumably due to elevated oxidative metabolism [236].
Taken together, all these ﬁndings provide indirect evidences
for the hypothesis that ROS production and subsequent induction of
ROS defense are essential contributors to longevity. To prove this
hypothesis, the previously described inhibitor of glycolysis, DOG, was
applied to C. elegans, resulting in a decrease in glucose availability
followed by a compensatory increase in respiration [23]. The increase
in oxygen consumption was associated with an increase in ROS
formation and a consequent induction of antioxidant enzyme activity,
ﬁnally leading to life-span extension [23]. Most importantly, simul-
taneous treatment with various antioxidants completely abolished
this life-span-extending effect of DOG, suggesting that an increase in
ROS formation is essential for CR-induced promotion of longevity [23].
These ﬁndings were corroborated by very recent studies that
examine the effect of CR in S. cerevisiae and Schizosaccharomyces
pombe [24,25,27]. Correspondingly, an increased mitochondrial
respiration and/or a subsequent enhanced ROS production after CR
were observed [24,25,27]. Hence, similar to the above-mentioned
observations in C. elegans, activation of stress response pathways as
well as induction of defense mechanisms has been discussed as
representing the underlying life-span-extending mechanisms
[24,25,27,188–190]. It should be noted that endogenously produced
ROS presumably not only induce ROS defense enzymes, but also
increase activities of phase II response enzymes that protect from
damage beyond ROS. On a hypothetical basis this would explain the
clearly opposite effects of supplementation with exogenous antiox-
idants and/or genetic overexpression of antioxidant enzymes, on the
one hand, and endogenous response to endogenous ROS production
on the other hand. Future research will also have to investigate
whether response mechanisms to stressors such as endogenous ROS
may be less likely to be activated at higher age.
Physical exercise
Consistent with the concept of mitohormesis, glucose restriction
leads to an increase in mitochondrial activity accompanied by an
increase in respiration-derived ROS formation that serves as a
mild stressor (Fig. 1). This ROS signal is able to induce conserved



































Fig. 1. Life-span-extending interventions generate mitochondrial ROS signals to activate longevity-promoting genes. For calorie and especially glucose restriction, but also for
physical exercise, evidence exists that these interventions extend life span in various model organisms, but also increase mitochondrial metabolism. This activation promotes
formation of mitochondrial ROS signals that cause an adaptive response (mitohormesis) in the nucleus to promote longevity. The possible link to impaired insulin/IGF-1 signaling,
however, remains to be experimentally shown.
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factors) that culminate in an overall adaptive response, represented
by an improvement in antioxidant capacity and ﬁnally longevity.
Cotreatment with antioxidants inhibits ROS signal transduction and
prevents the adaptive response. Thus, glucose-restriction-mediated
longevity is abolished.
Therefore, interventions that induce mitochondrial function seem
to be promising in regard to regulation of life expectancy. Accordingly,
moderate physical activity, an intervention that is known to be health
beneﬁcial in a broad spectrum [120,121,237–239], is assumed to
cause induction of mitochondrial metabolism and ROS production
[240–242]. Moreover, health-promoting effects were demonstrated to
be reduced if subjects exposed to physical activity were cotreated
with antioxidant supplements [186,243].
Conclusions
Taken together, the data summarized and discussed in this review
support the conclusion that CR, glucose restriction, and moderate
physical activity share, at least in part, common mechanistic features
that may inﬂuence the aging process, i.e., enhanced mitochondrial
activity and subsequently increased ROS formation that ultimately
induce an adaptive response (increased defense mechanisms and
improved stress resistance), which culminates in metabolic health
and extended longevity.
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